Clinical trials: Massive Blood Transfusion; Thrombocytopenia
Thromboembolus, Massive Blood Transfusion; Thrombocytopenia
Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion
This study aims to compare the incidence of thromboembolic complications among trauma patients receiving PCC, rFVIIa, both agents, or neither during massive transfusion.
- Conditions
- Thromboembolus, Massive Blood Transfusion; Thrombocytopenia, Trauma
- Trial name
- NCT07290634
- Testing
- Number of Participants with massive blood transfusion
- Where
- 2 sites in United States
- Volunteers
- 75 people
- Sponsor
- Zeliha Alicikus
Massive Hemorrhage, Massive Blood Loss
Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia
This is a retrospective descriptive study, to study the treatment indications, changes in transfusion need, coagulation profiles changes and clinical outcome (survival, complication) of non-haemophiliac patients who received…
- Conditions
- Massive Hemorrhage, Massive Blood Loss, Massive Blood Transfusion; Thrombocytopenia
- Trial name
- NCT03251547
- Testing
- NovoSeven
- Where
- Malaysia
- Volunteers
- 76 people
- Sponsor
- Universiti Sains Malaysia